Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP375868.RAlulihXaSIQ8uh0auIdvkrlKm2k6uuLShybfJl_alkWM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP375868.RAlulihXaSIQ8uh0auIdvkrlKm2k6uuLShybfJl_alkWM130_assertion type Assertion NP375868.RAlulihXaSIQ8uh0auIdvkrlKm2k6uuLShybfJl_alkWM130_head.
- NP375868.RAlulihXaSIQ8uh0auIdvkrlKm2k6uuLShybfJl_alkWM130_assertion description "[The frequencies of several aberrations varied with type of therapy, eg, 5q- was more frequent in radiotherapy-associated t-MDS, monosomy 7 was more common in t-AML and t-MDS after treatment with alkylators, and t(11q23) in t-AML was associated with topoisomerase II inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP375868.RAlulihXaSIQ8uh0auIdvkrlKm2k6uuLShybfJl_alkWM130_provenance.
- NP375868.RAlulihXaSIQ8uh0auIdvkrlKm2k6uuLShybfJl_alkWM130_assertion evidence source_evidence_literature NP375868.RAlulihXaSIQ8uh0auIdvkrlKm2k6uuLShybfJl_alkWM130_provenance.
- NP375868.RAlulihXaSIQ8uh0auIdvkrlKm2k6uuLShybfJl_alkWM130_assertion SIO_000772 12454741 NP375868.RAlulihXaSIQ8uh0auIdvkrlKm2k6uuLShybfJl_alkWM130_provenance.
- NP375868.RAlulihXaSIQ8uh0auIdvkrlKm2k6uuLShybfJl_alkWM130_assertion wasDerivedFrom befree-2016 NP375868.RAlulihXaSIQ8uh0auIdvkrlKm2k6uuLShybfJl_alkWM130_provenance.
- NP375868.RAlulihXaSIQ8uh0auIdvkrlKm2k6uuLShybfJl_alkWM130_assertion wasGeneratedBy ECO_0000203 NP375868.RAlulihXaSIQ8uh0auIdvkrlKm2k6uuLShybfJl_alkWM130_provenance.